3696.HK
INSILICO
HK$61.95
-1.43%
2026-02-27
About INSILICO
InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, software solutions, business development, new drug discovery, and holding company businesses. The company has a strategic collaboration agreement with Suzhou Ribo Life Science Co., Ltd. for the development of oligonucleotide therapeutics; and strategic collaboration with Human Life Foundation Models, Inc. for the development of foundation models for human longevity science. It operates in Hong Kong, the United States, the United Kingdom, Kingdom of Saudi Arabia, Japan, Denmark, the United Arab Emirates, Korea, Mainland China, Germany, Switzerland, Taiwan, and internationally. The company was founded in 2014 and is based in New Territories, Hong Kong.
Key Fundamentals
Forward P/E
-530.54
EPS (TTM)
HK$-35.10
Revenue Growth (YoY)
10.1%
Profit Margin
0.0%
Debt/Equity
1.32
Price/Book
6.54
Market Cap
HK$23.80B
Avg Volume (10D)
3.8M
Recent Breakout Signals
No recent breakout signals detected for 3696.HK.
Recent Price Range (60 Days)
60D High
HK$80.90
60D Low
HK$29.98
Avg Volume
3.6M
Latest Close
HK$61.95
Get breakout alerts for 3696.HK
Sign up for Breakout Scanner to receive daily notifications when 3696.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
INSILICO (3696.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 3696.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 3696.HK operates in the Technology sector within the Software - Infrastructure industry. Data is provided for informational purposes only and does not constitute financial advice.